InvestorsObserver
×
News Home

Revolution Medicines Inc (RVMD) has risen 16.15% in a Week, Should You Buy?

Tuesday, August 09, 2022 02:35 PM | InvestorsObserver Analysts

Mentioned in this article

Revolution Medicines Inc (RVMD) has risen 16.15% in a Week, Should You Buy?

Revolution Medicines Inc (RVMD) is near the top in its industry group according to InvestorsObserver. RVMD gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Revolution Medicines Inc gets a 70 rank in the Biotechnology industry. Biotechnology is number 30 out of 148 industries.

Overall Score - 64
RVMD has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on RVMD!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Revolution Medicines Inc Stock Today?

Revolution Medicines Inc (RVMD) stock is trading at $23.66 as of 2:34 PM on Tuesday, Aug 9, a decline of -$0.74, or -3.03% from the previous closing price of $24.40. The stock has traded between $23.24 and $24.74 so far today. Volume today is less active than usual. So far 309,816 shares have traded compared to average volume of 1,035,845 shares. Click Here to get the full Stock Report for Revolution Medicines Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App